John O's most recent trade in Village Super Market, Inc. - Ordinary Shares - Class A was a trade of 16,406 CLASS A COMMON STOCK done . Disclosure was reported to the exchange on March 27, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Village Super Market Inc (Class A) | John L. Van Orden | CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2026 | 16,406 | 40,023 (0%) | 0% | 0 | CLASS A COMMON STOCK | |
| Lemaitre Vascular Inc | John J. O'Connor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Mar 2026 | 1 | 1 | - | - | Dividend Equivalent Rights | |
| B&G Foods Inc | John A. Ozgopoyan | EVP of Sales | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2026 | 37,571 | 37,571 (0%) | 0% | 0 | Common Stock | |
| Village Super Market Inc (Class A) | John L. Van Orden | CFO & Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.79 per share. | 17 Mar 2026 | 13,361 | 23,617 (0%) | 0% | 42.8 | 571,717 | CLASS A COMMON STOCK |
| NVIDIA | John O. Dabiri | Director | Sale of securities on an exchange or to another person at price $ 184.90 per share. | 13 Mar 2026 | 3,004 | 14,788 (0%) | 0% | 184.9 | 555,440 | Common |
| Preformed Line Products Co | John J. Olenik | VP-Research & Engineering | Sale or transfer of securities back to the company at price $ 260.84 per share. | 12 Mar 2026 | 752 | 0 (0%) | 0% | 260.8 | 196,152 | Common shares, $2 par value |
| Jefferson Cap Inc | John J. Oros | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2026 | 25,000 | 25,000 | - | - | Stock option (right to buy) | |
| Jefferson Cap Inc | John J. Oros | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2026 | 25,000 | 25,000 | - | - | Stock option (right to buy) | |
| Freshpet Inc | John Gregory O’Connor | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2026 | 4,814 | 12,314 (0%) | 0% | 0 | Common Stock | |
| Cactus Inc (Class A) | John A. O'Donnell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2026 | 2,559 | 5,083 | - | - | Restricted Stock Units | |
| Cactus Inc (Class A) | John A. O'Donnell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2026 | 2,524 | 2,559 | - | - | Restricted Stock Units | |
| Cactus Inc (Class A) | John A. O'Donnell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2026 | 2,524 | 27,990 (0%) | 0% | - | Class A Common Stock | |
| MSC Income Fund Inc | John O. Niemann | Director | Purchase of securities on an exchange or from another person at price $ 12.42 per share. | 09 Mar 2026 | 1,887 | 38,726 | - | 12.4 | 23,437 | Common Stock |
| BeiGene Ltd (ADR) | John V. Oyler | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2026 | 326,976 | 5,491,339 (0%) | 0% | 0 | Ordinary Shares | |
| BeiGene Ltd (ADR) | John V. Oyler | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2026 | 117,936 | 5,609,275 (0%) | 0% | 0 | Ordinary Shares | |
| Westinghouse Air Brake Tech | John A. Olin | Executive Vice President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2026 | 5,917 | 61,893 (0%) | 0% | 0 | Common Stock - Direct | |
| Westinghouse Air Brake Tech | John A. Olin | Executive Vice President & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 263.02 per share. | 02 Mar 2026 | 4,511 | 55,976 (0%) | 0% | 263.0 | 1,186,461 | Common Stock - Direct |
| Herc Holdings Inc | John A. Olin | Director | Purchase of securities on an exchange or from another person at price $ 142.47 per share. | 27 Feb 2026 | 3,000 | 3,320 (0%) | 0% | 142.5 | 427,410 | Common Stock |
| Westinghouse Air Brake Tech | John A. Olin | Executive Vice President & CFO | Sale of securities on an exchange or to another person at price $ 263.30 per share. | 24 Feb 2026 | 11,000 | 60,487 (0%) | 0% | 263.3 | 2,896,300 | Common Stock - Direct |
| Bruker Corp | John A. Ornell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2026 | 4,520 | 39,732 (0%) | 0% | 0 | Common Stock | |
| Westinghouse Air Brake Tech | John A. Olin | Executive Vice President & CFO | Grant, award, or other acquisition of securities at price $ 257.52 per share. | 12 Feb 2026 | 27,917 | 85,322 (0%) | 0% | 257.5 | 7,189,325 | Common Stock - Direct |
| Westinghouse Air Brake Tech | John A. Olin | Executive Vice President & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 257.52 per share. | 12 Feb 2026 | 13,835 | 71,487 (0%) | 0% | 257.5 | 3,562,858 | Common Stock - Direct |
| Tractor Supply | John P. Ordus | EVP Chief Stores Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 54.09 per share. | 12 Feb 2026 | 680 | 96,031 (0%) | 0% | 54.1 | 36,782 | Common stock |
| Tractor Supply | John P. Ordus | EVP Chief Stores Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2026 | 28,070 | 28,070 | - | - | Employee stock option | |
| Tractor Supply | John P. Ordus | EVP Chief Stores Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2026 | 6,270 | 96,711 (0%) | 0% | 0 | Common stock | |
| Tractor Supply | John P. Ordus | EVP Chief Stores Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 54.78 per share. | 08 Feb 2026 | 596 | 90,441 (0%) | 0% | 54.8 | 32,647 | Common stock |
| Entergy | John O. Hudson | Chief External Affairs Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 97.96 per share. | 06 Feb 2026 | 204 | 15,294 (0%) | 0% | 98.0 | 19,984 | Common Stock |
| Tractor Supply | John P. Ordus | EVP Chief Stores Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 54.87 per share. | 05 Feb 2026 | 747 | 91,038 (0%) | 0% | 54.9 | 40,986 | Common stock |
| Preformed Line Products Co | John J. Olenik | VP-Research & Engineering | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2026 | 1,160 | 8,493 (0%) | 0% | 0 | Common shares, $2 par value | |
| Preformed Line Products Co | John J. Olenik | VP-Research & Engineering | Payment of exercise price or tax liability using portion of securities received from the company at price $ 245.42 per share. | 04 Feb 2026 | 987 | 7,506 (0%) | 0% | 245.4 | 242,230 | Common shares, $2 par value |
| Preformed Line Products Co | John J. Olenik | VP-Research & Engineering | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2026 | 441 | 441 | - | - | Restricted stock units | |
| Akebia Therapeutics Inc | Erik John Ostrowski | SVP, CFO, CBO & Treasurer | Sale of securities on an exchange or to another person at price $ 1.39 per share. | 02 Feb 2026 | 34,951 | 672,635 (0%) | 0% | 1.4 | 48,582 | Common Stock |
| Akebia Therapeutics Inc | Erik John Ostrowski | SVP, CFO, CBO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2026 | 320,000 | 320,000 | - | - | Stock Option (Right to buy) | |
| Akebia Therapeutics Inc | Erik John Ostrowski | SVP, CFO, CBO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2026 | 204,000 | 707,586 (0%) | 0% | 0 | Common Stock | |
| Entergy | John O. Hudson | Chief External Affairs Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2026 | 6,673 | 6,673 | - | - | Employee Stock Option (Right to Buy) | |
| Entergy | John O. Hudson | Chief External Affairs Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2026 | 1,655 | 15,498 (0%) | 0% | 0 | Common Stock | |
| Entergy | John O. Hudson | Chief External Affairs Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 94.97 per share. | 26 Jan 2026 | 239 | 13,843 (0%) | 0% | 95.0 | 22,698 | Common Stock |
| Entergy | John O. Hudson | Chief External Affairs Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 93.19 per share. | 25 Jan 2026 | 270 | 14,082 (0%) | 0% | 93.2 | 25,161 | Common Stock |
| Ensign Grp Inc | John O. Agwunobi | Director | Sale of securities on an exchange or to another person at price $ 179.82 per share. | 20 Jan 2026 | 246 | 9,233 (0%) | 0% | 179.8 | 44,236 | Common Stock |
| Ensign Grp Inc | John O. Agwunobi | Director | Sale of securities on an exchange or to another person at price $ 178.31 per share. | 20 Jan 2026 | 146 | 9,087 (0%) | 0% | 178.3 | 26,033 | Common Stock |
| Entergy | John O. Hudson | Chief External Affairs Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2026 | 8,014 | 17,843 (0%) | 0% | 0 | Common Stock | |
| Entergy | John O. Hudson | Chief External Affairs Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 95.67 per share. | 15 Jan 2026 | 3,491 | 14,352 (0%) | 0% | 95.7 | 333,984 | Common Stock |
| Ensign Grp Inc | John O. Agwunobi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2026 | 600 | 9,479 (0%) | 0% | 0 | Common Stock | |
| AnaptysBio Inc | John A. Orwin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 8,250 | 8,250 | - | - | Stock Option (right to buy) | |
| AnaptysBio Inc | John A. Orwin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 6,000 | 6,000 | - | - | Restricted Stock Unit | |
| Goosehead Insurance Inc (Class A) | John Terry O'Connor | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 15,000 | 15,000 | - | - | Employee Stock Options (right to buy) | |
| Herc Holdings Inc | John A. Olin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2026 | 320 | 320 (0%) | 0% | 0 | Common Stock | |
| Preformed Line Products Co | John J. Olenik | VP-Research & Engineering | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 1,000 | 7,333 (0%) | 0% | 0 | Common shares, $2 par value | |
| Preformed Line Products Co | John J. Olenik | VP-Research & Engineering | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 1,000 | 0 | - | - | Restricted stock units | |
| BeiGene Ltd (ADR) | John V. Oyler | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 310.48 per share. | 15 Dec 2025 | 16,318 | 28,957 (0%) | 0% | 310.5 | 5,066,489 | American Depositary Shares |
| BeiGene Ltd (ADR) | John V. Oyler | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 308.41 per share. | 15 Dec 2025 | 14,163 | 55,925 (0%) | 0% | 308.4 | 4,368,018 | American Depositary Shares |
| BeiGene Ltd (ADR) | John V. Oyler | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 309.37 per share. | 15 Dec 2025 | 10,650 | 45,275 (0%) | 0% | 309.4 | 3,294,798 | American Depositary Shares |
| BeiGene Ltd (ADR) | John V. Oyler | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 302.74 per share. | 15 Dec 2025 | 7,470 | 10,343 (0%) | 0% | 302.7 | 2,261,492 | American Depositary Shares |
| BeiGene Ltd (ADR) | John V. Oyler | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 302.29 per share. | 15 Dec 2025 | 6,389 | 91,820 (0%) | 0% | 302.3 | 1,931,331 | American Depositary Shares |
| BeiGene Ltd (ADR) | John V. Oyler | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 304.37 per share. | 15 Dec 2025 | 5,829 | 84,095 (0%) | 0% | 304.4 | 1,774,160 | American Depositary Shares |
| BeiGene Ltd (ADR) | John V. Oyler | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 303.72 per share. | 15 Dec 2025 | 5,442 | 3,268 (0%) | 0% | 303.7 | 1,652,855 | American Depositary Shares |
| BeiGene Ltd (ADR) | John V. Oyler | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 307.38 per share. | 15 Dec 2025 | 5,118 | 70,088 (0%) | 0% | 307.4 | 1,573,168 | American Depositary Shares |
| BeiGene Ltd (ADR) | John V. Oyler | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 306.39 per share. | 15 Dec 2025 | 4,949 | 75,206 (0%) | 0% | 306.4 | 1,516,335 | American Depositary Shares |
| BeiGene Ltd (ADR) | John V. Oyler | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 305.55 per share. | 15 Dec 2025 | 3,940 | 80,155 (0%) | 0% | 305.6 | 1,203,867 | American Depositary Shares |
| BeiGene Ltd (ADR) | John V. Oyler | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 301.79 per share. | 15 Dec 2025 | 2,567 | 19,325 (0%) | 0% | 301.8 | 774,699 | American Depositary Shares |
| BeiGene Ltd (ADR) | John V. Oyler | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 311.33 per share. | 15 Dec 2025 | 2,344 | 26,613 (0%) | 0% | 311.3 | 729,749 | American Depositary Shares |
| BeiGene Ltd (ADR) | John V. Oyler | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 304.36 per share. | 15 Dec 2025 | 1,973 | 40 (0%) | 0% | 304.4 | 600,507 | American Depositary Shares |
| BeiGene Ltd (ADR) | John V. Oyler | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 303.60 per share. | 15 Dec 2025 | 1,896 | 89,924 (0%) | 0% | 303.6 | 575,629 | American Depositary Shares |
| BeiGene Ltd (ADR) | John V. Oyler | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 300.80 per share. | 15 Dec 2025 | 1,877 | 22,492 (0%) | 0% | 300.8 | 564,597 | American Depositary Shares |
| BeiGene Ltd (ADR) | John V. Oyler | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 301.58 per share. | 15 Dec 2025 | 1,791 | 98,209 (0%) | 0% | 301.6 | 540,127 | American Depositary Shares |
| BeiGene Ltd (ADR) | John V. Oyler | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 303.13 per share. | 15 Dec 2025 | 1,633 | 8,710 (0%) | 0% | 303.1 | 495,013 | American Depositary Shares |
| BeiGene Ltd (ADR) | John V. Oyler | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 302.31 per share. | 15 Dec 2025 | 1,512 | 17,813 (0%) | 0% | 302.3 | 457,097 | American Depositary Shares |
| BeiGene Ltd (ADR) | John V. Oyler | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 304.13 per share. | 15 Dec 2025 | 1,255 | 2,013 (0%) | 0% | 304.1 | 381,685 | American Depositary Shares |
| BeiGene Ltd (ADR) | John V. Oyler | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 314.92 per share. | 15 Dec 2025 | 1,194 | 24,369 (0%) | 0% | 314.9 | 376,009 | American Depositary Shares |
| BeiGene Ltd (ADR) | John V. Oyler | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 313.52 per share. | 15 Dec 2025 | 929 | 25,563 (0%) | 0% | 313.5 | 291,256 | American Depositary Shares |
| BeiGene Ltd (ADR) | John V. Oyler | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 300.98 per share. | 15 Dec 2025 | 600 | 21,892 (0%) | 0% | 301.0 | 180,586 | American Depositary Shares |
| BeiGene Ltd (ADR) | John V. Oyler | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 311.93 per share. | 15 Dec 2025 | 121 | 26,492 (0%) | 0% | 311.9 | 37,743 | American Depositary Shares |
| BeiGene Ltd (ADR) | John V. Oyler | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 305.25 per share. | 15 Dec 2025 | 40 | 0 (0%) | 0% | 305.3 | 12,210 | American Depositary Shares |
| Lemaitre Vascular Inc | John J. O'Connor | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2025 | 5 | 62,350 (0%) | 0% | 0 | Common Stock | |
| Lemaitre Vascular Inc | John J. O'Connor | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2025 | 5 | 0 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | John J. O'Connor | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2025 | 5 | 0 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | John J. O'Connor | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2025 | 5 | 62,345 (0%) | 0% | 0 | Common Stock | |
| Lemaitre Vascular Inc | John J. O'Connor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2025 | 3,431 | 3,431 | - | - | Stock Option (Right to Buy) | |
| Lemaitre Vascular Inc | John J. O'Connor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2025 | 533 | 62,340 (0%) | 0% | 0 | Common Stock | |
| Lemaitre Vascular Inc | John J. O'Connor | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 3 | 61,807 (0%) | 0% | 0 | Common Stock | |
| Lemaitre Vascular Inc | John J. O'Connor | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 3 | 3 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | John J. O'Connor | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 2 | 4 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | John J. O'Connor | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 2 | 61,804 (0%) | 0% | 0 | Common Stock | |
| Lemaitre Vascular Inc | John J. O'Connor | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Dec 2025 | 3,000 | 61,801 (0%) | 0% | 0 | Common Stock | |
| Lemaitre Vascular Inc | John J. O'Connor | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Dec 2025 | 1 | 2 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | John J. O'Connor | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Dec 2025 | 1 | 61,802 (0%) | 0% | 0 | Common Stock | |
| Bank of America | Johnbull Okpara | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Nov 2025 | 26,784 | 26,784 (0%) | 0% | - | Common Stock | |
| Bank of America | Johnbull Okpara | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Nov 2025 | 26,784 | 53,569 | - | - | Restricted Stock Units | |
| Bank of America | Johnbull Okpara | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.65 per share. | 30 Nov 2025 | 13,674 | 13,110 (0%) | 0% | 53.6 | 733,610 | Common Stock |
| Goosehead Insurance Inc (Class A) | John Terry O'Connor | General Counsel | Purchase of securities on an exchange or from another person at price $ 71.81 per share. | 26 Nov 2025 | 2,100 | 3,100 (0%) | 0% | 71.8 | 150,801 | Class A Common Stock |
| NVIDIA | John O. Dabiri | Director | Sale of securities on an exchange or to another person at price $ 179.42 per share. | 24 Nov 2025 | 626 | 17,792 (0%) | 0% | 179.4 | 112,317 | Common |
| Lemaitre Vascular Inc | John J. O'Connor | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 7,500 | 0 | - | - | Stock Option (Right to Buy) | |
| Lemaitre Vascular Inc | John J. O'Connor | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 37.29 per share. | 21 Nov 2025 | 7,500 | 64,801 (0%) | 0% | 37.3 | 279,675 | Common Stock |
| BeiGene Ltd (ADR) | John V. Oyler | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 11 Nov 2025 | 858,533 | 6,441,041 (0%) | 0% | 0 | Ordinary Shares | |
| BeiGene Ltd (ADR) | John V. Oyler | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 11 Nov 2025 | 151,320 | 7,299,574 (0%) | 0% | 0 | Ordinary Shares | |
| Bruker Corp | John A. Ornell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.00 per share. | 06 Nov 2025 | 10,000 | 41,445 (0%) | 0% | 24 | 240,000 | Common Stock |
| Bruker Corp | John A. Ornell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Nov 2025 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| Bruker Corp | John A. Ornell | Director | Sale of securities on an exchange or to another person at price $ 39.00 per share. | 06 Nov 2025 | 6,233 | 35,212 (0%) | 0% | 39 | 243,087 | Common Stock |
| Ensign Grp Inc | John O. Agwunobi | Director | Sale of securities on an exchange or to another person at price $ 188.87 per share. | 06 Nov 2025 | 246 | 8,879 (0%) | 0% | 188.9 | 46,462 | Common Stock |
| Pacific Gas & Electric | John O. Larsen | Director | Purchase of securities on an exchange or from another person at price $ 15.96 per share. | 04 Nov 2025 | 7,500 | 18,111 (0%) | 0% | 16.0 | 119,700 | Common Stock |
| MSC Income Fund Inc | John O. Niemann | Director | Other type of transaction at price $ 12.65 per share. | 31 Oct 2025 | 758 | 36,839 | - | 12.6 | 9,588 | Common Stock |